• Banner

  • Reduced price
Chronic Traumatic Encephalopathy

Chronic Traumatic Encephalopathy

Proceedings of the Boston University Alzheimer's Disease Center Conference

9780323544252
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 30 DAYS
423,31 zł
359,81 zł Save 63,50 zł Tax included
Lowest price within 30 days before promotion: 359,81 zł
Quantity
Available in 4-6 weeks

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DHL, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Description

Get a thorough, expert overview of the many key facets of chronic traumatic encephalopathy (CTE) with this concise, practical resource by Drs. Andrew E. Budson, Ann C. McKee, Robert C. Cantu, and Robert A. Stern. This easy-to-read reference is based on lectures from Boston Universitys Alzheimers Disease Centers November 2016 two-day conference on CTE.

Product Details
Elsevier
59356
9780323544252
9780323544252

Data sheet

Rok wydania
2017
Numer wydania
1
Oprawa
twarda
Liczba stron
198
Wymiary (mm)
191 x 235
Waga (g)
570
  • 1 History of Concussion and Chronic Traumatic Encephalopathy
    2 Pathology of Chronic Traumatic Encephalopathy
    3 Chronic Traumatic Encephalopathy: Clinical Presentation and Diagnostic Criteria
    4 Biomechanics of Head Trauma
    5 Mechanisms of Concussion, Traumatic Brain Injury, and Chronic Traumatic Encephalopathy: Acute and Chronic Effects of Blast Exposure
    6 Family Panel Discussion
    7 Genetics of Chronic Traumatic Encephalopathy
    8 Comorbid Pathology in Chronic Traumatic Encephalopathy
    9 Differential Diagnosis and Treatment of Chronic Traumatic Encephalopathy
    10 Fluid Biomarkers for Mild Traumatic Brain Injury and Chronic Traumatic Encephalopathy
    11 Toward Imaging Chronic Traumatic Encephalopathy
    12 From Chronic Traumatic Encephalopathy Biomarkers to Therapeutics: What We Need to Know to Design Clinical Trials
    13 Athlete Panel Discussion
Comments (0)